DiaMedica Therapeutics Inc.
-
Ticker
DMAC
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 1-10 Employees
- Based in Minneapolis, Minnesota
DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments for neurological and kidney diseases. DiaMedica鈥檚 common shares are listed on The Nasdaq Capital Market under the trading symbol 鈥淒MAC.鈥�
DiaMedica Therapeutics Inc.
Most Recent Annual Report
MOST RECENT
2023 Annual Report and Form 10K
Older/Archived Annual Reports